- Home
- CNC
as 04-14-2025 4:00pm EST
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
| Founded: | 1984 | Country: | United States |
| Employees: | N/A | City: | ST LOUIS |
| Market Cap: | 31.7B | IPO Year: | 2001 |
| Target Price: | $80.43 | AVG Volume (30 days): | 4.5M |
| Analyst Decision: | Buy | Number of Analysts: | 15 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 6.31 | EPS Growth: | 27.48 |
| 52 Week Low/High: | $55.03 - $80.59 | Next Earning Date: | 04-25-2025 |
| Revenue: | $147,169,000,000 | Revenue Growth: | 4.08% |
| Revenue Growth (this year): | 17.99% | Revenue Growth (next year): | 2.43% |
Latest Centene Corporation News
CNC Breaking Stock News: Dive into CNC Ticker-Specific Updates for Smart Investing
Insider Monkey
4 days ago
Is Centene Corporation (CNC) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?
Zacks
4 days ago
Centene Extends SilverSummit's Presence to the Edges of Nevada
Zacks
4 days ago
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
MT Newswires
5 days ago
Centene Unit Gets Nevada Medicaid Contract
PR Newswire
5 days ago
CENTENE SUBSIDIARY SILVERSUMMIT HEALTHPLAN AWARDED NEVADA MEDICAID CONTRACT
Morningstar Research
5 days ago
Analyst Report: Centene Corporation
PR Newswire
5 days ago
Health Net and Centene Foundation Invest More than $9 Million in Initiatives to Expand and Strengthen California's Physician Workforce
MT Newswires
6 days ago
Guggenheim Initiates Centene at Neutral
Compare CNC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CNC Centene Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.